The Senate Finance Committee is demanding top insulin makers explain why prices for the lifesaving drug are so high.
Category: Modern Healthcare
Providers push back against conflict of interest concerns for Joint Commission, other accreditors
Industry stakeholders told the CMS that they oppose banning accrediting organizations like the Joint Commission from providing consulting services.
Planned Parenthood barred from Title X under final draft rule
The controversial regulation from HHS would bar funding to any clinic that performs abortions and reshape the Title X family planning network.
Woman’s Hospital CEO Teri Fontenot to retire this summer
Her retirement will cap a 23-year tenure leading the Baton Rouge, La., hospital, which has grown to become the state’s largest birthing hospital and neonatal ICU.
Burnout among physicians drops but depression on the rise, AMA survey finds
About 44% of doctors reported a burnout symptom in 2017, down from 2014 when 54% of doctors reported burnout, a new survey of 5,197 physicians from the AMA found.
Thousands could lose Medicaid coverage in Louisiana
Louisiana’s health department has notified tens of thousands of Medicaid recipients that they could be booted from the program, after a newly used computer check found they earn too much money to receive the taxpayer-financed health coverage.
White House wants to hear about insurers’ challenges with grandfathered ACA plans
The Trump administration wants to know what challenges employer and group health plans face in maintaining grandfathered status for Affordable Care Act plans.
UPMC seeks to join antitrust case against Blues plans
UPMC is seeking to join antitrust litigation against Blue Cross and Blue Shield in hopes of contracting with Blues plans.
Florida governor hopes his state will be first to import drugs from Canada
Florida’s Republican governor wants his state to become the first to import drugs from Canada, and he is asking his friend President Donald Trump for help.
U.S. government joins lawsuit against Abbott companies
The units bought by Abbott Laboratories are accused of submitting false Medicare claims for unnecessary devices for diabetic patients and paying kickbacks to the patients.
